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Abstract 
Background: The National Central Cancer Registry (NCCR) collected population-based cancer registration data in 
2012 from local registries and estimated the cancer incidence and mortality in China.
Methods: In the middle of 2015, 261 cancer registries submitted reports on new cancer cases and deaths occurred 
in 2012. Qualified data from 193 registries were used for analysis after evaluation. Crude rates, number of cases, and 
age-standardized rates stratified by area (urban/rural), sex, age group, and cancer type were calculated according to 
the national population in 2012.
Results: The covered population were 198,060,406 from 193 qualified cancer registries (74 urban and 119 rural reg-
istries). The major indicators of quality control, percentage of cases morphologically verified (MV%), death certificate-
only cases (DCO%), and the mortality to incidence (M/I) ratio, were 69.13%, 2.38%, and 0.62, respectively. It was esti-
mated that there were 3,586,200 new cancer cases and 2,186,600 cancer deaths in 2012 in China with an incidence 
of 264.85/100,000 [age-standardized rate of incidence by the Chinese standard population (ASRIC) of 191.89/100,000] 
and a mortality of 161.49/100,000 [age-standardized rate of mortality by the Chinese standard population (ASRMC) 
of 112.34/100,000]. The ten most common cancer sites were the lung, stomach, liver, colorectum, esophagus, female 
breast, thyroid, cervix, brain, and pancreas, accounting for approximately 77.4% of all new cancer cases. The ten lead-
ing causes of cancer death were lung cancer, liver cancer, gastric cancer, esophageal cancer, colorectal cancer, pancre-
atic cancer, female breast cancer, brain tumor, leukemia, and lymphoma, accounting for 84.5% of all cancer deaths.
Conclusions: Continuous cancer registry data provides basic information in cancer control programs. The cancer 
burden in China is gradually increasing, both in urban and rural areas, in males and females. Efficient cancer preven-
tion and control, such as health education, tobacco control, and cancer screening, should be paid attention by the 
health sector and the whole society of China.
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The National Central Cancer Registry (NCCR) called for 
data in 2012 from all population-based cancer registries 
in China, and the datasets were used to update the annual 
estimation for new cancer cases and deaths in China after 
data evaluation and analysis.
There were 261 cancer registries, located in 32 prov-
inces, autonomous regions, or municipalities, submitted 
cancer data in 2012. All data were checked and evaluated 
according to the criteria of data quality from NCCR, and 
193 registries’ data were qualified and accepted for this 
updated cancer statistics in China in 2012. Cancer reg-
istries collected information on new cancer cases from 
hospitals, community health centers, medical insurance 
agents, and the Vital Statistics System (for cases only 
identified by death certification). Registries obtained 
information on cancer deaths from the death surveil-
lance system, which collects death information from 
hospitals and the Civil Administration Bureau with avail-
able cremation records. Population information was col-
lected from local statistical bureau or household register 
department in local public security bureau. Proportion of 
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morphological verification (MV%), percentage of cancer 
cases identified with death certification only (DCO%), 
mortality to incidence (M/I) ratio, percentage of uncerti-
fied cancer (UB%), and percentage of cancer with unde-
fined or unknown primary site (secondary) (O&U%) 
were used to evaluate the completeness, validity, and reli-
ability of cancer statistics. Pooled data were stratified by 
area (urban/rural), sex, age group, and cancer site. Can-
cer incident cases and deaths were estimated using age-
specific rates, which were stratified by area (urban/rural), 
sex (male/female), and age (grouped by 0, 1–4, 5–9,…, 
80–84, 85-year old and above). The Chinese population 
census in 2000 and the Segi’s population were used for 
age-standardized rates (ASR) of incidence/mortality. The 
national incidences and mortalities were estimated using 
stratified rates and modelled national population in 2012.
All 193 cancer registries (74 urban and 119 rural 
registries) covered a total of 198,060,406 population 
(100,450,109 in urban areas and 97,610,297 in rural 
areas). The overall indicators MV%, DCO%, and M/I ratio 
were 69.13%, 2.38%, and 0.62, respectively. They were 
70.63%, 2.63%, and 0.59 in urban registries, compared to 
67.31%, 2.09%, and 0.65 in rural registries. The estimates 
of new cases and deaths were 3,586,200 and 2,186,600 in 
2012, respectively.
The crude cancer incidence in China was 264.85/100,000 
(289.30/100,000 in males and 239.15/100,000 in females), 
and age-standardized rates of incidence by the Chinese 
standard population (ASRIC) and by the world stand-
ard population (ASRIW) were 191.89/100,000 and 
187.83/100,000 with a cumulative rate (for the whole pop-
ulation of 0–74 years old) of 21.82%. The crude incidence 
and ASRIC were 277.17/100,000 and 195.56/100,000 in 
urban areas and were 251.20/100,000 and 187.10/100,000 
in rural areas. Cancer incidence was relatively low before 
40 years old, after then increased dramatically, and finally 
peaked after 80  years old and slightly decreased after 
85 years old. The pattern was similar between urban and 
rural areas (Table 1).
The crude cancer mortality in China was 
161.49/100,000 (198.99/100,000 in males and 
122.06/100,000 in females), age-standardized rates of 
mortality by the Chinese standard population (ASRMC) 
and by the world standard population (ASRMW) were 
112.34/100,000 and 111.25/100,000, and the cumula-
tive mortality (for the whole population of 0–74  years 
old) was 12.61%. The crude mortality and ASRMC were 
159.00/100,000 and 107.23/100,000 in urban areas and 
were 164.24/100,000 and 118.22/100,000 in rural areas. 
The cancer mortality was relatively low before 45  years 
old and then dramatically increased, reaching the peak 
after 85 years old. The mortality in rural areas was high-
est in the age group of 80–84 years old. The age-specific 
mortality in males was lower in urban areas than in rural 
areas in most of age groups before 80 years old (Table 2).
Lung cancer was the most common cancer in all areas, 
followed by gastric, liver, colorectal, and esophageal 
cancers with estimated new cases of 704,800, 423,500, 
366,100, 331,300, and 286,700, respectively. Lung can-
cer was the most frequently diagnosed cancers in males, 
followed by gastric, liver, esophageal, and colorectal 
cancers; breast cancer was the most common cancer in 
females, followed by lung, colorectal, gastric, and cervi-
cal cancers (Table  3; Figs.  1, 2). The ten most common 
cancers accounted for approximately 77.4% of all cancer 
cases in urban and rural areas. In urban areas, lung can-
cer was the most frequently diagnosed cancer, followed 
by colorectal, gastric, female breast, and liver cancers. 
Table 1 Cancer incidence in China in 2012 (This table has been published previously and is reproduced with permission 
from the Chinese Journal of Cancer Research, see Ref. [3])
ASRIC age-standardized rate of incidence by the China population in 2000, ASRIW age-standardized rate of incidence by the Segi’s population
a  The cumulative rate of the whole population of 0–74 years old
Areas Sex New cases (×103) Crude incidence (1/105) ASRIC (1/105) ASRIW (1/105) Cumulative rate (%)a
All areas Both 3586.2 264.85 191.89 187.83 21.82
Male 2007.6 289.30 216.17 214.33 25.39
Female 1578.6 239.15 170.08 163.81 18.32
Urban areas Both 1973.0 277.17 195.56 190.88 21.91
Male 1062.0 292.31 212.68 210.63 24.71
Female 911.0 261.39 181.30 174.00 19.28
Rural areas Both 1613.2 251.20 187.10 183.91 21.67
Male 945.6 286.00 220.03 218.42 26.14
Female 667.6 214.28 156.14 151.35 17.14
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Lung cancer had been becoming the most frequently 
diagnosed cancer (326,600 new cases with an incidence 
of 50.86/100,000), followed by gastric, esophageal, liver, 
and colorectal cancers.
Lung cancer was the first leading cause of cancer death 
in China, followed by liver, gastric, esophageal, and colo-
rectal cancers with estimated deaths of 569,400, 321,200, 
298,500, 210,900, and 159,300, respectively. In males, 
lung cancer was the leading cause of cancer death, fol-
lowed by liver, gastric, esophageal, and colorectal can-
cers; whereas in females, lung cancer was still the leading 
cause of cancer death, followed by gastric, liver, colorec-
tal, and esophageal cancers (Table 4; Figs. 1, 2). The top 
ten leading causes of cancer death accounted for approxi-
mately 84.5% of all cancer deaths. The cancer patterns 
showed difference between urban and rural areas and 
between males and females. The leading causes of cancer 
death in rural areas were lung, liver, gastric, esophageal, 
and colorectal cancers, whereas the leading causes of 
cancer death in urban areas was lung, liver, gastric, colo-
rectal, and esophageal cancers.
Compared with the figures in 2011 [1] and 2010 [2], 
cancer burden kept increasing, mostly because of the 
population increase and aging. Timely report of cancer 
registry provides basic information for policymakers, 
researchers, and clinicians. With the registry data getting 
Table 2 Cancer mortality in China in 2012 (This table has been published previously and is reproduced with permission 
from the Chinese Journal of Cancer Research, see Ref. [3])
ASRMC age-standardized rate of mortality by the China population in 2000, ASRMW age-standardized rate of mortality by the Segi’s population
a  The cumulative rate of the whole population of 0–74 years old
Areas Sex Deaths (×103) Crude mortality (1/105) ASRMC (1/105) ASRMW (1/105) Cumulative rate (%)a
All areas Both 2186.6 161.49 112.34 111.25 12.61
Male 1380.9 198.99 146.51 145.57 16.57
Female 805.7 122.06 80.00 78.89 8.66
Urban areas Both 1131.8 159.00 107.23 106.13 11.70
Male 706.2 194.37 138.60 137.74 15.30
Female 425.7 122.14 77.74 76.55 8.18
Rural areas Both 1054.8 164.24 118.22 117.06 13.63
Male 674.7 204.06 155.46 154.28 17.99
Female 380.1 121.98 82.64 81.60 9.21
Table 3 Top ten cancer incidences in China in 2012 (This table is modified from a previous publication with permission, 
see Ref. [3])
CNS central nervous system
Incidence Proportion ASRIC Incidence Proportion ASRIC
 (1/105) (%) (1/105)  (1/105) (%) (1/105)
1  Lung 469.9 67.71 23.41 49.62  Breast 272.7 41.32 17.28 30.43
2  Stomach 297.9 42.93 14.84 31.60  Lung 234.9 35.59 14.88 23.56
3  Liver 274.0 39.48 13.65 29.48  Colorectum 142.2 21.55 9.01 14.54
4  Esophagus 203.0 29.25 10.11 21.37  Stomach 125.6 19.03 7.96 12.85
5  Colorectum 189.1 27.24 9.42 20.18  Cervix 98.5 14.93 6.24 11.39
6  Bladder 57.0 8.21 2.84 6.01  Liver 92.1 13.95 5.83 9.37
7  Prostate 56.5 8.14 2.82 5.90  Thyroid 89.7 13.58 5.68 11.28
8  Pancreas 49.5 7.14 2.47 5.24  Esophagus 83.7 12.68 5.30 8.27
9  Brain, CNS 43.6 6.28 2.17 5.16  Uterus 61.6 9.34 3.90 6.72
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Fig. 1 Cancer incidence and mortality in urban and rural areas for 
males in China in 2012 (1/100,000). CNS central nervous system
Fig. 2 Cancer incidence and mortality in urban and rural areas for 
females in China in 2012 (1/100,000). CNS central nervous system
Table 4 Top ten cancer mortalities in China in 2012 (This table is modified from a previous publication with permission, 
see Ref. [3])
CNS central nervous system
Mortality Proportion ASRMC Mortality Proportion ASRMC
 (1/105) (%) (1/105)  (1/105) (%) (1/105)
1  Lung 386.6 55.71 28.00 40.64  Lung 182.8 27.70 22.69 17.67
2  Liver 237.7 34.25 17.21 25.40  Stomach 92.6 14.02 11.49 8.97
3  Stomach 205.9 29.67 14.91 21.72  Liver 83.5 12.65 10.36 8.31
4  Esophagus 149.1 21.48 10.80 15.63  Colorectum 68.2 10.34 8.47 6.45
5  Colorectum 91.1 13.13 6.60 9.54  Esophagus 61.9 9.37 7.68 5.82
6  Pancreas 44.4 6.40 3.22 4.68  Breast 61.6 9.33 7.64 6.43
7 Hematologic system 30.6 4.41 2.22 3.70  Pancreas 33.1 5.01 4.10 3.19
8  Brain, CNS 29.8 4.30 2.16 3.42  Cervix 24.5 3.72 3.04 2.64
9 Lymph nodes 26.2 3.78 1.90 2.87  Brain, CNS 23.8 3.60 2.95 2.64
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more accurate, it plays more important role in cancer 
control in China.
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